13

Lung damage usually develops against the background of a long course of rheumatoid arthritis, when manifestations of polyserositis develop: pleuritis, pericarditis, which have a favourable prognosis in most cases. In some cases, patients have changes characteristic of interstitial pneumonia (pneumonitis): dyspnoea, intrusive cough, at first dry and then moist, an abundance of fine bubbling and crepitating wheezes. Autoimmune mechanisms play a major role in the pathogenesis of pulmonary involvementin rheumatoid arthritis. In response to nonspecific antigenic influence there is activation of immunocompetent cells of pulmonary interstitium

  • Ўқишлар сони 13
  • Нашр санаси 05-04-2025
  • Мақола тилиIngliz
  • Саҳифалар сони7-13
English

Lung damage usually develops against the background of a long course of rheumatoid arthritis, when manifestations of polyserositis develop: pleuritis, pericarditis, which have a favourable prognosis in most cases. In some cases, patients have changes characteristic of interstitial pneumonia (pneumonitis): dyspnoea, intrusive cough, at first dry and then moist, an abundance of fine bubbling and crepitating wheezes. Autoimmune mechanisms play a major role in the pathogenesis of pulmonary involvementin rheumatoid arthritis. In response to nonspecific antigenic influence there is activation of immunocompetent cells of pulmonary interstitium

№ Муаллифнинг исми Лавозими Ташкилот номи
1 Zokirova A.M. ! Tashkent Pediatric Medical Institute, Uzbekistan
№ Ҳавола номи
1 1. [Chichasova NV, Vladimirov SA, ImametdinovaGR, et al. Functional outcomes of rheumatoid arthritis during various proceduresof anti-inflammatory therapy. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practiсе. 2010;(2):30–6. (In Russ.)]. DOI: http://dx.doi.org/10.14412/1995-4484-2010-1413.2. Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990;322(18):1277–89. DOI:http://dx.doi.org/10.1056/NEJM199005033221805.3. Bestaev DV, Karateev DE, Nasonov EL. Pulmonary involvement in rheumatoid arthritis. Rheumatology Science and Practice. 2014;52(4):451–457.DOI: http://dx.doi.org/10.14412/1995-4484-2014-451-4574. [Kop'evaTN. Patologiya revmatoidnogoartrita [Pathology of rheumatoid arthritis]. Moscow: Meditsina;1980. 208 p.]5. Даукш И.А.,Муратходжаева А.В., Пирназарова Г.З., Хакимрва У.Р. Системные заболевания соединительной ткани: ювенильный ревматоидный артрит (особенности клиники, диагностики и современные методы лечения -Ташкент 2018. С-76. УДК: 616-053.2:616.72-002.77C 40. ISBN 978-9943-5536-0-6 6. Thurlbeck WM, Miller LL, Muller NL, Rosenow EC. Diffuse disseases of the lung. Philadelphia; 1991. 243.7. [Nasonov EL, Nasonova VA. Revmatologiya. Natsional'noe rukovodstvo [Rheumatology. National Guide]. Moscow: GEOTAR-Media, 2008. 737 p.]8. Atkins SR, Matteson EL, Myers JL, et al. Morphological andquantitative assessment of mast cells in rheumatoid arthritis associated non-specific interstitial pneumonia and usual interstitial pneumonia. Ann Rheum Dis. 2006;65(5):677–80. DOI: http://dx.doi.org/10.1136/ard.2005.043877.9. [Il'kovich MM.Disseminirovannye zabolevaniya legkikh] [Disseminirovanny disseases of lungs]. Moscow: GEOTAR-Media; 2011. 480 p.]10. Masuko K, Murata M, Xiang Y, et al. Tryptase enhances release ofvascular endothelial growth factor from human osteoarthriticchondrocytes. Clin Exp Rheumatol. 2007;25(6):860–5.11. Selman M, Talmadge E, King E, Pardo A. Idiopathic pulmonaryfibrosis: prevailing and evolving hypotheses about its pathogenesisand implications for therapy. Ann Intern Med. 2001;134(2):136–51. DOI: http://dx.doi.org/10.7326/0003-4819-134-2-200101160-00015.12. [Sigidin YaA, Guseva NG, Ivanova MM. Diffuznye bolezni soedinitel'noi tkani [Diffusion diseases of connecting fabric]. Moscow: Meditsina; 1994. 544 p.]13 [PaleevNR, Tsar'kovaLN. Pulmonary syndromes at rheumatic diseases. In: Bolezni organov dykhaniya [Diseases of respiratory organs].Moscow: Meditsina; 1990. P. 4394–424.]14. Wiedemann HP, MatthayRA. Pulmonary manifestations of thecollagen vascular diseases. Clin Chest Med. 1989;10(4):677–722.15. Balbir-Gurman A, Yigla M, Nahir AM, Braun-Moscovici Y.Rheumatoid pleural effusion. Semin Arthritis Rheum.2006;35(6):368–78. DOI: http://dx.doi.org/10.1016/j.semarthrit.2006.03.002. 16. Diederich S, Roos N, Schmte-Linneweber B, et al. HRCT derLunge bei Kollagenosen. Radiologe. 1996;36(7):567–78. DOI:http://dx.doi.org/10.1007/s001170050112.17. Dawson JK, FewinsHE, Desmond I, et al Fibrosing alveolitis inpatients with rheumatoid arthritis as assessed by high resolutioncomputer tomography, chest radiography and puhnonary functiontests. Thorax. 2001;56(8):622–27. DOI: http://dx.doi.org/10.1136/thorax.56.8.622.18. Hakala M. Poor prognosis in.patients with rheumatoid arthritishospitalized for interstitial lung fibrosis. Chest. 1988;93(1):114–18.DOI: http://dx.doi.org/10.1378/chest.93.1.114.19. Lee YH, Kim YR, Ji JD, et al. A case of BOOP developed duringbucillamine treatment for rheumatoid arthritis. Korean J Intern Med. 2001;16(I):36–9.20. Godeau В, Coutant-Perronne V, Le Thi Huong D, et al Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases. J Rheumatol. 1994;21(2):246–51. 21. Bernscherer G, Karabelyos C, Tarjan Z. The pulmonological manifestations of rheumatoid arthritis. Orv Hetil. 2008;149(29):1355–61. DOI: 10.1556/OH.2008.28385.22. Minagawa S, Takayanagi К, НагаK, et al. A case of rheumatoidarthritis complicated with methotrexate-induced pneumonitis andPneumocystis pneumonia. Nihon Kokyuki Gakkai Zasshi. 2008;46(3):237–42.23. Cho I, Mori S, Imamura F, et al. Methotrexate pneumonia lackingdyspnea and radiographic interstitial patterns during treatment forearly rheumatoid arthritis: bronchoalveolar lavage and transbronchial lung biopsy in a differential diagnosis. Mod Rheumatol.2007;17(3):256–61. DOI: http://dx.doi.org/10.3109/s10165-007-0578-7.24. Buchbinder R, Barber M, Heuzenroeder L, et al. Incidence ofmelanoma and other malignancies among rheumatoid arthritispatients treated with methotrexate. Arthritis Rheum. 2008;59(6):794–9. DOI: http://dx.doi.org/10.1002/art.23716.25. Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoidarthritis. Arthritis Res Ther. 2008;10(2):45–8. DOI: http://dx.doi.org/10.1186/ar2404.26. Malik S, Toberty E, Thalayasingam N, et al. Natural history ofrheumatoid arthritis related interstitial lung disease. Rheumatology(Oxord). 2012;51(3):79.27[NasonovEL, edittor. Revmatologiya. Klinicheskierekomendatsii[Rheumatology. Clinical recommendations]. 2nd ed., ispr. i dop. Moscow: GEOTAR-Media; 2010.165 p.]28. [Mazurov VI, Bogdanov AN. Diagnosis and treatment of pulmonary lesion in patients with rheumatoid arthritis. Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practiсе. 2003;(1):52–6. (In Russ,)]. DOI: http://dx.doi.org/10.14412/1995-4484-2003-1136.29. Saper V.E. Chen G. Deutsch G.H. et al. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019;78(12): 1722-1731. Doi: 10.1136/annrheumdis-2019-216040.
Кутилмоқда